About PROTEIOS TECHNOLOGY, INC.
Proteios Technology develops next-generation cell isolation devices for gene and cell therapies, enabling high efficiency and automated cell isolation, activation, transduction, and expansion. The company also offers protein purification kits for research and commercial applications.
Next-generation cell isolation using multiple markersHigh efficiency, high yield, automated cell isolation, activation, transduction, and expansionClosed-system cell isolationProtein purification kits (FPLC, Gravity, Spin)Commercialization of cell therapy manufacturing platforms
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING | Department of Health and Human Services | $2.0M | |
| Federal contract award | Department of Health and Human Services | $455K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PROTEIOS TECHNOLOGY, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.